NMN Dosage Guide: How Much Should You Actually Take? (2026)

The NMN (nicotinamide mononucleotide – the direct precursor your body converts into NAD+) dosing landscape is a mess. Products range from 125mg to 1,500mg per serving. Marketing claims have nothing to do with clinical evidence. And the people who should be guiding this conversation – the researchers running human trials – are often drowned out by supplement marketers optimizing for "more is better" psychology.

This guide cuts through the noise. Every dosing recommendation here is traced to a specific human clinical trial, with sample sizes, durations, and measured outcomes. No animal extrapolation. No theoretical modeling. Just what the human data shows about how much NMN to take, when to take it, and how to take it.

Quick Facts: NMN

• Dose: 600 mg/day
• Form: Oral, ≥99% purity (Uthever)
• Timing: Morning with food
• Evidence: Strong (20+ human RCTs)
• Who it's for: Adults 40+ seeking NAD+ restoration

TL;DR

• The evidence-supported daily dose is 600mg – the dose that produced the strongest functional outcomes in the largest RCT (Yi et al. 2023, n=80)
• 250mg raises NAD+ but produces weaker functional benefits than 600mg
• 900mg does NOT outperform 600mg – more is not better beyond the threshold
• Take NMN in the morning with food – this aligns with the natural NAD+ circadian peak
• Sublingual absorption may bypass first-pass metabolism but lacks comparative human trial data
• No loading phase is needed – steady-state NAD+ elevation occurs within 2–4 weeks
• David Sinclair takes 1g daily; Bryan Johnson takes 500mg, 6 days/week

The Dose-Response Curve: What the Clinical Data Shows

The single most important study for NMN dosing is Yi et al., 2023, published in GeroScience. Here is why:

Yi et al., 2023 – The Dose-Optimization Study

Design: 80 middle-aged adults (40–65), multicenter double-blind randomized controlled trial (RCT – a study where participants are randomly assigned to treatment or placebo, with neither group knowing their assignment), 60 days.

Doses tested: 300mg, 600mg, 900mg NMN, and placebo.

Key findings:

The critical finding: 600mg produced the best functional outcomes. Not 300mg (too low for peak effect) and not 900mg (no additional benefit despite higher NAD+ levels).

This creates an inverted-U dose-response curve (a pattern where moderate doses produce the best effect, while both lower and higher doses are less effective) – a pattern common in biology where there is an optimal zone above which additional input does not produce additional benefit and may even reduce it. For a side-by-side evidence comparison of NMN against all major longevity compounds, see the Compound Index.

Why 900mg Doesn't Beat 600mg

This requires understanding NAD+ biology. When you flood the system with excess NMN:

1. NNMT upregulation: The enzyme NNMT (nicotinamide N-methyltransferase – an enzyme that methylates excess nicotinamide, consuming methyl groups from SAM) methylates excess nicotinamide into 1-methylnicotinamide (MeNAM), consuming methyl groups from SAM (S-adenosylmethionine, the universal methyl donor). Higher NMN doses may accelerate methyl depletion, potentially offsetting benefits. This is why TMG pairing matters – see TMG: The Methylation Partner Your NMN Needs.
2. Feedback regulation: Cells regulate NAD+ pools via multiple degradation enzymes (CD38, CD157, PARP). When NAD+ exceeds cellular requirements, degradation enzymes increase activity. More precursor does not automatically mean more sustained NAD+.
3. Gut conversion ceiling: A 2025 study in Nature Metabolism (Cuenoud et al.) showed that gut bacteria convert a significant portion of oral NMN to nicotinic acid (NA). This gut-mediated pathway may have a saturation point beyond which additional NMN is not efficiently converted.

Key Takeaway: 600mg NMN is the evidence-supported optimal daily dose. The Yi et al. 2023 trial (n=80) is the only human study to directly compare multiple NMN doses, and 600mg produced the strongest functional improvements. Higher doses waste money and methyl groups without providing additional benefit.

The Full Dosing Continuum: 250mg to 1,200mg

Here is every dose that has been tested in human trials and what each one achieved:

250mg/day

Trials: Igarashi et al. 2022 (n=25), Yoshino et al. 2021 (n=25), Katayoshi et al. 2024 (n=34), Fukamizu et al. 2022 (n=30)

What it does: Reliably elevates blood NAD+ levels. Improves insulin sensitivity in metabolically compromised populations (Yoshino). Improves walking speed in older men with low baseline fitness (Igarashi). Improves sleep quality (Katayoshi).

Limitations: Functional benefits are more pronounced in people with existing impairments. Healthy, fit individuals may not notice effects at this dose.

Verdict: The minimum effective dose. Appropriate for those who want conservative NAD+ support, are under 50, or are using NMN as part of a broader supplement strategy.

300mg/day

Trial: Yi et al. 2023 (n=80, 300mg arm)

What it does: Significant NAD+ elevation. Moderate improvement in physical performance metrics.

Verdict: Better than 250mg for functional outcomes, but still suboptimal compared to 600mg.

600mg/day

Trial: Yi et al. 2023 (n=80, 600mg arm)

What it does: Significant NAD+ elevation with the strongest improvement in the 6-minute walk test and overall physical performance.

Verdict: The clinical sweet spot. Best risk-to-benefit ratio. This is the dose supported by the strongest evidence.

900mg/day

Trial: Yi et al. 2023 (n=80, 900mg arm)

What it does: Significant NAD+ elevation comparable to 600mg. No additional functional benefit. Higher methyl group depletion.

Verdict: No advantage over 600mg. Not recommended unless directed by a physician monitoring biomarkers.

1,000mg (1g)/day

No controlled trial at this exact dose. This is the dose David Sinclair – Harvard geneticist and author of Lifespan – has publicly stated he takes daily. His rationale is based on animal dose-conversion calculations from early mouse studies, not on human dose-optimization data. Sinclair has taken approximately 1g NMN since around 2018.

Verdict: Likely safe based on the 900mg trial data and the 1,250mg single-dose safety study (Huang 2022), but not demonstrated to be more effective than 600mg.

1,250mg/day

Trial: Huang et al. 2022 (single-dose safety study, n=12)

What it does: Safe single-dose administration with no adverse events. Blood NAD+ metabolites rose dose-dependently and normalized within 24 hours.

Verdict: Confirms safety at high single doses but does not provide chronic dosing efficacy data.

Key Takeaway: The evidence supports a clear dosing hierarchy: 250mg is the minimum effective dose for NAD+ elevation, 600mg is the optimal functional dose, and anything above 600mg shows no additional benefit. The 1g doses used by some longevity researchers are based on personal interpretation, not human dose-optimization data.

Timing: Morning vs Evening and Circadian NAD+ Rhythm

When you take NMN matters almost as much as how much you take.

The Circadian NAD+ Cycle

NAD+ (nicotinamide adenine dinucleotide – a coenzyme required for 500+ cellular processes including DNA repair and energy production) levels are not constant. They oscillate on a 24-hour circadian rhythm:

• Peak: Morning and early afternoon – NAD+ levels are highest when NAMPT (the rate-limiting enzyme in the NAD+ salvage pathway) expression is at its circadian maximum
• Trough: Evening and night – NAD+ declines as SIRT1 activity shifts to nighttime repair functions

This oscillation is regulated by the CLOCK-BMAL1 complex (the master transcription factors that control circadian gene expression), which directly controls NAMPT transcription. SIRT1 itself regulates CLOCK-BMAL1, creating a feedback loop: NAD+ → SIRT1 → CLOCK-BMAL1 → NAMPT → NAD+.

Why Morning Dosing Is Optimal

Taking NMN in the morning amplifies the natural circadian peak. This:

1. Maximizes daytime energy metabolism when mitochondrial activity is highest
2. Aligns with peak NAMPT expression, meaning your cells are already primed to process NMN
3. Avoids circadian disruption – taking NMN at night could artificially elevate NAD+ during the trough phase, potentially interfering with sleep-repair functions
4. Reduces side effects – GI symptoms and flushing are less common when NMN is taken with a morning meal

What the Researchers Do

• David Sinclair: Takes NMN in the morning, mixed with yogurt (the fat improves resveratrol absorption – NMN itself is water-soluble and does not require fat)
• Bryan Johnson: Takes NMN at approximately 11 AM, 6 days per week
• Andrew Huberman: Has mentioned morning dosing when discussing NAD+ precursors

Evening Dosing Concerns

Some users report vivid dreams or disrupted sleep architecture when taking NMN in the evening. While this is not documented in clinical trials (which typically specify morning administration), it is mechanistically plausible: elevated NAD+ shifts SIRT1 activity patterns, which directly regulate circadian clock genes.

If you work night shifts or have an atypical circadian schedule, take NMN within the first few hours after waking – regardless of clock time.

Key Takeaway: Take NMN in the morning with your first meal. This aligns with your body's natural NAD+ circadian peak, maximizes metabolic benefit during your active hours, and avoids the sleep disruption some users report with evening dosing. Every major longevity researcher who publicly discusses timing recommends morning administration.

Sublingual vs Oral: Does Delivery Method Matter?

This is one of the most debated questions in the NMN space. The argument for sublingual (under-the-tongue) delivery is that it bypasses first-pass hepatic metabolism (the process where the liver metabolizes substances before they reach systemic circulation), allowing more intact NMN to reach the bloodstream.

The Argument for Sublingual

NMN is water-soluble and has a molecular weight of 334 Da – small enough for mucosal absorption. The sublingual mucosa (the thin membrane under your tongue) has a dense capillary network that feeds directly into the systemic circulation, bypassing the liver's first-pass metabolism. In theory, this means higher bioavailability (the proportion of a substance that enters systemic circulation and produces an active effect).

The Argument Against

The 2025 gut-microbiome research (Cuenoud et al., Nature Metabolism) showed that a significant portion of NMN's NAD+-boosting effect comes from gut bacterial conversion to nicotinic acid, which then enters the Preiss-Handler pathway in the liver. Bypassing the gut entirely might eliminate this beneficial pathway.

Additionally, no head-to-head human trial has compared sublingual vs oral NMN. All clinical efficacy data – including the Yi et al. 2023 dose-optimization study – used standard oral delivery.

The Practical Reality

The oral cavity's pH and enzymatic environment may partially degrade NMN before absorption occurs. The residence time under the tongue (typically 30–60 seconds before swallowing) is short, and most of the dose likely ends up being swallowed and absorbed orally anyway.

Verdict: Oral NMN has all the human trial support. Sublingual NMN has a reasonable theoretical mechanism but no comparative human data. Until a head-to-head trial exists, oral delivery is the evidence-based choice. For more on how delivery method affects supplement absorption, see Bioavailability: Why the Form of Your Supplement Matters More Than the Dose.

Key Takeaway: Sublingual NMN has theoretical advantages for bypassing liver metabolism, but zero human trials have compared it to oral delivery. All published efficacy data used oral NMN. The recently discovered gut-microbiome conversion pathway actually argues for oral delivery. Stick with what the trials tested.

With Food or Without?

The Evidence

Clinical trials have used NMN both with and without food. The Yi et al. 2023 trial did not strictly control food timing. The Yoshino et al. 2021 trial administered NMN "in the morning."

The Practical Recommendation

Take NMN with food for three reasons:

1. Reduced GI side effects: The most common NMN side effect – mild nausea or bloating – is significantly less frequent when taken with a meal
2. Resveratrol pairing: If you take NMN alongside resveratrol (a polyphenol that activates sirtuin enzymes), the fat in your meal dramatically improves resveratrol absorption. NMN itself is water-soluble and absorbs fine either way, but the combination protocol benefits from food
3. Sustained absorption: Food slows gastric emptying, creating a more gradual absorption curve rather than a sharp spike. This may support more consistent NAD+ elevation throughout the day

NMN does not require fat for absorption (unlike resveratrol, CoQ10, or vitamin D). But the GI comfort benefit alone makes food timing worthwhile.

For those practicing intermittent fasting (IF – restricting eating to a defined window, typically 16 hours fasting / 8 hours eating), NMN can be taken during the fasting window without breaking your fast. NMN contains negligible calories and does not trigger an insulin response. However, if your IF window opens in the morning, taking NMN with your first meal is still preferable for GI comfort. See Intermittent Fasting and Longevity Supplements: What to Take When for complete timing guidance.

NMN Form and Quality: What Affects the Dose You Actually Absorb

The dose on the label is not the dose your cells receive. Several factors determine how much of your NMN reaches the bloodstream as intact NMN or effective NAD+ precursors:

Purity

Clinical trials use ≥99% pure NMN. Consumer products range from 80% to 99%+. A product listed at 500mg with 85% purity delivers only 425mg of actual NMN – the remainder is degradation products, precursors, or impurities. Always verify purity via a third-party certificate of analysis (CoA).

Stability

NMN degrades in the presence of heat, moisture, and light. A product manufactured at 99% purity but stored in a hot warehouse for months may arrive at your door with significantly lower NMN content. Enzymatically synthesized NMN (like Uthever) tends to be more stable than chemically synthesized alternatives. Cold storage or stabilized packaging extends shelf life.

The "Bioavailable Dose" Concept

For NMN specifically, the bioavailability question is more nuanced than for many supplements. The 2025 Nature Metabolism finding (Cuenoud et al.) that gut bacteria convert a significant fraction of oral NMN to nicotinic acid – which then produces NAD+ via the Preiss-Handler pathway in the liver – means that even NMN that does not survive intact through the gut still contributes to NAD+ production.

This dual pathway (direct SLC12A8 uptake + gut microbial conversion) means oral NMN's effective bioavailability is higher than the percentage of intact NMN that reaches the bloodstream. It also means that gut health influences NMN efficacy – another reason to support your microbiome.

Key Takeaway: NMN purity, stability, and your gut microbiome all affect how much of your dose translates to cellular NAD+ elevation. A 600mg dose of ≥99% pure, properly stored NMN likely delivers more NAD+-boosting potential than 1,000mg of degraded or low-purity product. Quality matters as much as dose.

Loading Phase: Needed or Not?

Short answer: not needed.

Some supplement protocols recommend a "loading phase" – taking a higher dose for the first 1–2 weeks before reducing to a maintenance dose. This makes sense for compounds with long tissue accumulation times (like creatine, which saturates muscle stores over ~7 days).

NMN does not work this way. The pharmacokinetics are straightforward:

• NMN enters the bloodstream within 15–30 minutes of oral dosing
• Blood NAD+ levels begin rising within hours
• Steady-state NAD+ elevation is typically achieved within 2–4 weeks of consistent daily dosing
• No trial has used a loading protocol, and none has found it necessary

Bryan Johnson – who rigorously tests every variable in his protocol – does not use a loading phase. David Sinclair does not either. No clinical researcher has recommended one.

Key Takeaway: No loading phase is required for NMN. Steady-state NAD+ elevation occurs within 2–4 weeks of consistent daily dosing at your target dose. Start at 250mg if you want a gentle introduction, then increase to 600mg after 1–2 weeks. No clinical trial has used or recommended a loading protocol.

Pairing NMN With TMG: The Methylation Math

Any serious NMN dosing discussion must address methylation. Here is why:

When your body metabolizes NMN into NAD+ and then uses that NAD+ through sirtuin and PARP enzymes, nicotinamide (NAM) is produced as a byproduct. NAM can be recycled back to NMN, but a portion is methylated by the enzyme NNMT (nicotinamide N-methyltransferase) into 1-methylnicotinamide (MeNAM). This reaction consumes a methyl group from SAM (S-adenosylmethionine – the universal methyl donor required for DNA methylation, gene regulation, and neurotransmitter synthesis).

The methylation cost scales with NMN dose. At 250mg, the methyl demand is modest. At 600mg, it is meaningful. At 1g, it is substantial.

David Sinclair has publicly stated he takes TMG (trimethylglycine – also called betaine, a methyl donor found in beets) at 500mg–1g alongside his NMN specifically to counteract this methyl drain. The rationale: if you are boosting NAD+ to support epigenetic maintenance via sirtuins, but simultaneously depleting the methyl groups that DNA methylation requires, you are working against yourself.

Practical pairing: At 600mg NMN, 250–500mg TMG provides adequate methyl replenishment. At 1g NMN, 500mg–1g TMG is more appropriate. TMG is water-soluble, inexpensive, and can be taken at the same time as NMN with no interaction. For the complete biochemistry, see TMG: The Methylation Partner Your NMN Needs.

Key Takeaway: NMN metabolism consumes methyl groups from the SAM pool. Higher NMN doses create proportionally greater methyl demand. Pairing NMN with TMG at a 1:0.5–1:1 ratio replenishes the methylation pool and prevents the paradox of boosting NAD+ at the expense of the epigenetic maintenance you are trying to support.

What the Longevity Researchers Actually Take

Publicly disclosed NMN dosing protocols from prominent longevity figures:

Note on researcher protocols: These individuals have access to extensive biomarker testing that informs their dosing decisions. Sinclair's 1g dose predates the Yi et al. 2023 dose-optimization study – which found 600mg optimal. Bryan Johnson's more conservative 500mg, 6 days/week approach may reflect the Yi data or his own biomarker optimization. Neither approach is "wrong" – they represent different risk-benefit assessments by individuals with different data.

Safety Note: Start at 250–300mg/day and increase gradually over 2–4 weeks. If you take medications metabolized by CYP enzymes or have liver/kidney conditions, consult your doctor before starting NMN.

Special Population Dosing Considerations

Adults Over 60

Older adults have the most depleted NAD+ levels and the most to gain from supplementation. The Igarashi et al. 2022 trial (n=25, ages 65+) and Katayoshi et al. 2024 trial (n=34, ages 65–75) both used 250mg and demonstrated significant benefits. The 600mg dose from Yi et al. 2023 was tested in ages 40–65.

Recommendation: Start at 250mg for 2 weeks, then increase to 600mg. Older adults with polypharmacy (taking multiple prescription medications) should have physician oversight.

Adults Under 40

NAD+ decline accelerates after age 40 but begins subtly in the 30s. Healthy adults under 40 with good metabolic health may not need NMN at all – lifestyle interventions (exercise, sleep, nutrition) may maintain adequate NAD+ levels.

Recommendation: If supplementing, 250–300mg is likely sufficient. 600mg is not harmful but may be unnecessary.

Athletes and High-Activity Individuals

Exercise itself boosts NAD+ through AMPK (AMP-activated protein kinase – a cellular energy sensor activated by exercise that triggers beneficial metabolic adaptations) activation and NAMPT upregulation. NMN may complement exercise-induced NAD+ elevation, but the interaction has not been studied in human trials.

Recommendation: 600mg, taken in the morning before training. The ergogenic (performance-enhancing) effects suggested by the Yi et al. 2023 6-minute walk test data are consistent with improved mitochondrial function, but dedicated athletic performance trials are needed.

Frequently Asked Questions

The Bottom Line: Take 600mg of NMN in the morning with food -- this is the dose validated by the largest human trial, and going higher wastes money and methyl groups without additional benefit.

Related Reading

• What Is NMN? The Complete Guide to Nicotinamide Mononucleotide
• NMN vs NR: Which NAD+ Precursor Should You Take?
• NMN Side Effects: What the Research Shows
• Intermittent Fasting and Longevity Supplements: What to Take When
• NAD+ Decline by Age: The Complete Decade-by-Decade Timeline
• TMG: The Methylation Partner Your NMN Needs

References:

• Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. GeroScience. 2023;45(1):29–43. n=80 RCT. Doses: 300mg, 600mg, 900mg.
• Igarashi M, et al. Chronic NMN supplementation elevates blood NAD+ and improves walking speed in older men. NPJ Aging. 2022;8(1):5. n=25. Dose: 250mg.
• Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. n=25. Dose: 250mg.
• Katayoshi T, et al. NMN supplementation improves walking speed and sleep quality in elderly adults. Nutrients. 2024;16(2):240. n=34. Dose: 250mg.
• Fukamizu Y, et al. Safety evaluation of β-nicotinamide mononucleotide oral administration. Front Nutr. 2022;9:868640. n=30. Dose: 250mg.
• Huang H, et al. Single-dose NMN safety and pharmacokinetics. 2022. n=12. Dose: up to 1,250mg.
• Cuenoud B, et al. Gut microbiota conversion of NMN to nicotinic acid. Nature Metabolism. 2025.
• 2024 Systematic Review. PMC11365583. 7 RCTs pooled.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.